Anthony J. Giovinazzo is a businessperson who founded Cervelo Pharmaceuticals Ltd. and who has been at the helm of 9 different companies. Currently, he holds the position of Executive Chairman at Sublimity Therapeutics Ltd. and Executive Chairman at Alpha Cognition, Inc.
He is also on the board of ZyVersa Therapeutics, Inc., ProMIS Neurosciences, Inc., Titan Medical, Inc. and Pond Technologies Holdings, Inc. and Member of Institute of Corporate Directors.
In his past career Anthony J. Giovinazzo occupied the position of President of Neurotrophic Bioscience, Inc., Chief Executive Officer of Cervelo Pharmaceuticals Ltd., President, Chief Executive Officer & Director at Cynapsus Therapeutics, Inc., President & Chief Executive Officer of Sunovion CNS Development Canada Ulc, President & Chief Executive Officer for Cita NeuroPharmaceuticals, Inc., President for PNO Resources Ltd., President at Nova Molecular, Inc. and Venture Partner at Nordion (Canada), Inc.
He received an MBA from International Institute for Management Development and an undergraduate degree from McMaster University.